XML 16 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 129 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Cash flows from operating activities:      
Loss used for the period $ (1,372,411) $ (1,056,921) $ (13,889,930)
Adjustments to reconcile loss for the period to net cash used in operating activities:      
Depreciation 12,741 10,398 145,227
Increase (decrease) in liability for employee rights upon retirement (5,945) 9,553 217,757
Stock-based compensation 197,237 189,355 1,428,140
Stock-based interest compensation to convertible notes holders       1,214,943
Change in the fair value of warrants with down-round protection (43,051)    (43,051)
Linkage difference on principal of loans from stockholders 5,869 (8,733) 182,918
Interest on convertible notes       78,192
Gain on sale of property and equipment       (912)
Gain from trading marketable securities       (12,920)
Changes in assets and liabilities:      
Decrease (increase) in other current assets (8,121) 27,658 (91,408)
Increase (decrease) in accounts payable 67,012 31,671 140,154
Increase (decrease) in other current liabilities 22,694 (80,814) 230,080
Net cash used in operating activities (1,123,975) (877,833) (10,400,810)
Cash flows from investment activities:      
Decrease (increase) in funds in respect of employee rights upon retirement (6,470) (11,699) (109,274)
Purchase of property and equipment (3,516) (47,750) (212,289)
Proceeds from sale of property and equipment       4,791
Investment in marketable securities       (388,732)
Proceeds from sale of marketable securities       406,995
Short-term loan granted to related party, net of repayments       (14,252)
Net cash used in investment activities (9,986) (59,449) (312,761)
Cash flows from financing activities      
Credit from banking institutions (repayment)    (18,977) (6,218)
Proceeds from issuance of convertible notes       1,144,000
Repayment of convertible notes       (527,396)
Proceeds from issuance of Common Stock, net of issuance expenses    934,829 10,406,380
Deferred offering cost         
Proceeds from stockholders loans       347,742
Net cash provided by financing activities    915,852 11,364,508
Effect of exchange rate changes on cash and cash equivalents (4,176) 28,457 107,430
Increase (decrease) in cash and cash equivalents (1,138,137) 7,027 758,367
Cash and cash equivalents at beginning of the period 1,896,504 1,494,248   
Cash and cash equivalents at end of the period 758,367 1,501,275 758,367
Supplementary information on financing activities not involving cash flows:      
Fair value of warrants with down-round protection issued in connection with Common Stock issuances $ 40,848 $ 83,899 $ 40,848